Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
SOHO State of the Art Updates and Next Questions | Manuscript Title: Bispecific T-Cell Engagers: Sequencing, B-Cell Maturation Antigen, GPRC5D, and Resistance.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 01, 2025
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
Journal: Blood cancer journal
Published: May 25, 2023
Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 10, 2023
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
Journal: Blood cancer journal
Published: October 07, 2022
Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
Journal: Blood cancer journal
Published: September 20, 2022
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
Journal: Blood cancer journal
Published: September 13, 2022
Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
Journal: American journal of hematology
Published: August 12, 2022
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial.
Journal: The Lancet. Haematology
Published: July 13, 2022
Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
Journal: British journal of haematology
Published: April 06, 2022
Last Updated: 09/26/2026